Pricing Log in Create free account

Akanda Corp. (AKAN) vs BioXcel Therapeutics, Inc. (BTAIQ)

Akanda Corp. and BioXcel Therapeutics, Inc. are both Drug Manufacturers Specialty & Generic companies. Akanda Corp. and BioXcel Therapeutics, Inc. are of similar size ($2.3M and $2.2M). Across the 8 metrics below, Akanda Corp. leads on 5 and BioXcel Therapeutics, Inc. on 3.

Valuation

Metric AKAN BTAIQ Drug Manufacturers Specialty & Generic median
P/E — n/m 20.55
P/S — 0.41 2.08
P/B n/m n/m 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales n/m 227.51 2.87
Earnings yield — (37,900.00%) (15.94%)
Free cash flow yield 0.00% (16,806.60%) 0.00%

Profitability

Metric AKAN BTAIQ Drug Manufacturers Specialty & Generic median
Gross margin — 53.10% 53.51%
Operating margin — (6,054.72%) 0.00%
Net margin — (9,549.87%) (2.45%)
Free cash flow margin 0.00% (6,860.38%) 0.00%
Return on equity 0.00% 63.52% (0.80%)
Return on assets 0.00% (259.62%) (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AKAN BTAIQ Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (14.52%) 5.22%
EPS growth (last fiscal year) (139.63%) 75.63% 42.91%
Revenue growth, 5-year CAGR 161.77% — 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AKAN BTAIQ Drug Manufacturers Specialty & Generic median
Debt to equity (0.70) (0.90) 0.04
Current ratio 0.22 0.21 2.41
Net debt to EBITDA (2.75) (1.61) 1.01

Dividend

Metric AKAN BTAIQ Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric AKAN BTAIQ Drug Manufacturers Specialty & Generic median
Market cap 2.24m 2.31m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack